UBS Group Reaffirms “Buy” Rating for Hamilton Lane (NASDAQ:HLNE)

Hamilton Lane (NASDAQ:HLNE)‘s stock had its “buy” rating restated by analysts at UBS Group in a report released on Thursday, Marketbeat.com reports. They currently have a $166.00 price target on the stock. UBS Group’s price target suggests a potential upside of 27.51% from the stock’s previous close.

Several other equities analysts have also issued reports on HLNE. Weiss Ratings lowered Hamilton Lane from a “buy (b-)” rating to a “hold (c+)” rating in a report on Saturday, October 25th. Wall Street Zen raised Hamilton Lane from a “sell” rating to a “hold” rating in a research report on Sunday, November 9th. Keefe, Bruyette & Woods upped their price objective on Hamilton Lane from $150.00 to $158.00 and gave the company an “outperform” rating in a research note on Thursday, November 6th. The Goldman Sachs Group raised Hamilton Lane from a “neutral” rating to a “buy” rating and set a $165.00 target price for the company in a research report on Thursday, November 6th. Finally, Oppenheimer set a $181.00 price target on shares of Hamilton Lane and gave the stock an “outperform” rating in a report on Tuesday, October 14th. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $160.13.

Hamilton Lane Stock Down 2.3%

HLNE opened at $130.19 on Thursday. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.49 and a quick ratio of 3.49. The company’s 50-day moving average is $123.30 and its 200 day moving average is $139.67. Hamilton Lane has a fifty-two week low of $111.98 and a fifty-two week high of $179.19. The firm has a market capitalization of $7.26 billion, a P/E ratio of 23.59 and a beta of 1.33.

Hamilton Lane (NASDAQ:HLNE) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $1.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.46. The business had revenue of $190.88 million during the quarter, compared to the consensus estimate of $171.86 million. Hamilton Lane had a net margin of 31.12% and a return on equity of 29.43%. Research analysts expect that Hamilton Lane will post 4.97 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Juan Delgado-Moreira acquired 8,000 shares of the stock in a transaction that occurred on Friday, November 7th. The shares were acquired at an average cost of $130.35 per share, for a total transaction of $1,042,800.00. Following the purchase, the chief executive officer owned 1,314,447 shares of the company’s stock, valued at approximately $171,338,166.45. The trade was a 0.61% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 22.21% of the company’s stock.

Institutional Investors Weigh In On Hamilton Lane

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Kayne Anderson Rudnick Investment Management LLC bought a new stake in shares of Hamilton Lane during the 1st quarter valued at $432,772,000. Millennium Management LLC grew its holdings in Hamilton Lane by 418.8% during the 3rd quarter. Millennium Management LLC now owns 1,060,511 shares of the company’s stock valued at $142,946,000 after buying an additional 856,112 shares in the last quarter. Champlain Investment Partners LLC bought a new stake in shares of Hamilton Lane during the first quarter valued at about $112,887,000. T. Rowe Price Investment Management Inc. increased its position in shares of Hamilton Lane by 63.4% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company’s stock valued at $189,555,000 after buying an additional 494,637 shares during the period. Finally, Norges Bank purchased a new stake in shares of Hamilton Lane in the second quarter worth about $46,641,000. Institutional investors own 97.40% of the company’s stock.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.